-REWRITE study will evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple escalating doses of KRRO-110
-First participant dosing anticipated in the first qu… [+7564 chars]
Lifestyle Natural Medicines
Korro Receives Australian HREC Approval and CTN Clearance to Initiate Phase 1/2a Clinical Study (REWRITE) of KRRO-110 for Alpha-1 Antitrypsin Deficiency
-REWRITE study will evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple escalating doses of KRRO-110 ...
 of KRRO-110 for Alpha-1 Antitrypsin Deficiency&url=https://worldnews.easybranches.com//lifestyle/natural-medicines/14943197&media=https://worldnews.easybranches.com/images/2024/12/750x495/14943197.jpg){kind=link}